Replies to post #9561 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Do not dispute that. Sorrento is a target and the BOD knows that it is. The reason to run hard and run fast with acquisitions, Chinese partners and the 100 Million preferred share poison pill. Sorrento can run for several year bleeding money before they will have to seriously consider a larger companies courtship. Time is rarely on your side and when you believe it is, it is an illusion.
A EUA only lasts as long as the Emergency lasts.
Here is where Sorrento needs to be for COVI-MSC and ABIVERTINIB. Multiple uses.
https://www.fda.gov/patients/learn-about-drug-and-device-approvals/fast-track-breakthrough-therapy-accelerated-approval-priority-review

Really like your list.
Really want to see what comes from ANP/Sorrento merger and I want to see soon.